IBM contributes massive chemical database to NIH to speed drug discovery9 December 2011 IBM has announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the National Institutes of Health. This data will allow researchers to more easily visualize important relationships among chemical compounds to aid in drug discovery and support advanced cancer research. In collaboration with Bristol-Myers Squibb, DuPont and Pfizer,
IBM is The publicly available chemical data can be used by researchers worldwide to gain new insights and enable new areas of research. It will also help researchers save time by more efficiently finding information buried in millions of pages of patent documents. Access to this data will also allow researchers to analyze far larger sets of documents than the traditional manual process, adding a whole new dimension to the ability to search intellectual property. The data was extracted using the IBM business analytics and optimization strategic IP insight platform (SIIP), a combination of data and analytics delivered via the IBM SmartCloud, and developed by IBM Research in collaboration with several major life sciences organizations. This is a new cloud-driven method for curating and analyzing massive amounts of patents, scientific content and molecular data. It uses techniques such as automated image analysis and enhanced optical recognition of chemical images and symbols to extract information from patents and literature upon publication. This is a task that otherwise takes weeks and months to complete manually, but can be done rapidly using this new technology. “Information overload continues to be a challenge in drug discovery and other areas of scientific research,” said Steve Heller, project director for the InChI Trust, a non-profit which supports the InChI international standard to represent chemical structures. “Rich data and content is often buried in patents, drawings, figures and scholarly articles. This contribution by IBM and its collaborators will make it easier for researchers to use this data, link to other data using the InChI structure representation and derive new insight.” Over the past six years, several major life sciences
organizations have “The scientific community will receive enormous benefit from this The data will be contributed to the National Center for
Biotechnology Further information The National Institutes of Health will make the content available
on More information about IBM SIIP is available at www.ibm.com/gbs/bao/siip
|
|||